Plain-English translation of NCT07542938 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the Medeliver Intracranial Drug-Coated Balloon Catheter, a specialized medical device that doctors thread through blood vessels to open narrowed arteries inside the brain. The device delivers medication directly to the narrowed area to help prevent it from closing again. Researchers are comparing this new treatment to a standard balloon catheter to see which is safer and more effective for patients who have experienced stroke symptoms caused by hardened arteries in the brain.
Brain arteries can narrow due to plaque buildup (atherosclerosis), which puts patients at high risk for stroke. Current treatments don't always prevent the arteries from narrowing again. This study exists to see whether the medication coating on the new balloon can better prevent this re-narrowing and improve outcomes for patients.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will undergo a minimally invasive procedure where doctors use a catheter (thin tube) to reach the narrowed artery in your brain and place the drug-coated balloon to open it. You will be randomly assigned to receive either the new Medeliver balloon or a standard balloon catheter. The procedure itself is performed in a hospital under anesthesia. After the procedure, you will have follow-up visits to check how well the artery stays open and to monitor your recovery and any side effects.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
China